Graves' Disease During Immune Reconstitution After Highly Active Antiretroviral Therapy for HIV Infection: Evidence of Thymic Dysfunction
- 1 February 2004
- journal article
- case report
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 20 (2) , 157-162
- https://doi.org/10.1089/088922204773004879
Abstract
A patient with HIV infection who experienced immune reconstitution after highly active antiretroviral therapy (HAART) [increase in CD4 T cell count from 600/μl] presented with severe Graves' disease 32 months after commencing HAART. A comprehensive clinical and laboratory study demonstrated pronounced regional lymphadenopathy and thymic enlargement at presentation, and that the onset of thyrotropin receptor antibody production was associated with increased production of soluble CD30 (a marker of type 2 immune responses). Blood naive CD8 T cell counts and TREC levels in both CD4 and CD8 T cells were increased at multiple time points compared with carefully selected controls. We conclude that the Graves' disease in this patient was associated with abnormally high blood counts of thymus-derived T cells, and propose that Graves' disease after HAART in this and other HIV patients may result from failure to delete autoreactive T cell clones in the regenerating thymus.Keywords
This publication has 36 references indexed in Scilit:
- Antithyrotropin Receptor Antibody: An UpdateThyroid®, 2001
- Alopecia universalis and Graves’ disease in the setting of immune restoration after highly active antiretroviral therapyAIDS, 2001
- Sequential Occurrence of Thyroid Autoantibodies and Graves' Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected PatientsJournal of Clinical Endocrinology & Metabolism, 2000
- Graves' DiseaseNew England Journal of Medicine, 2000
- Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapyThe American Journal of Medicine, 2000
- Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapyHIV Medicine, 2000
- High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.Journal of Clinical Investigation, 1998
- Highly active antiretroviral therapyThe Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Increased Serum Concentration of Soluble CD30 in Patients with Graves' Disease and Hashimoto's ThyroiditisJournal of Clinical Endocrinology & Metabolism, 1997